Visible Genetics cooperates with Virology Networks:
This article was originally published in Clinica
Executive Summary
Visible Genetics and Utrecht, Netherlands-based Virology Networks have formed a joint venture, Visible Molecular Standards (VMS), to produce quality control and quantitative standards for identifying HIV, Hepatitis B and C, CMV and other infectious organisms. Visible Genetics, of Toronto, Canada, will contribute 35,000 shares and will finance the development of the joint venture. VMS will also set up a database of existing and new HIV genotypes, as well as their resistance to specific HIV drugs, in Europe and the US.